Overview
Injectable anti-inflammatories, anticoagulants, anti-infectives, anticancer drugs and even cotton wools are in short supply. Like many others in France, the pharmacy at Rennes hospital is constantly on the edge. Over the past two decades, shortages of medicines and health products have increased twe...
Introduction
In this latest movie review, we dive deep into Médicaments : Les Profits de la pénurie (2022), exploring its intricate plot and standout performances that have everyone talking.
Injectable anti-inflammatories, anticoagulants, anti-infectives, anticancer drugs and even cotton wools are in short supply. Like many others in France, the pharmacy at Rennes hospital is constantly on the edge. Over the past two decades, shortages of medicines and health products have increased twentyfold in Europe. With almost all laboratories affected, practitioners and health establishments are forced to juggle with quotas to make up for shortages. Some even have to prioritise patients in terms of access to treatments, according to scales established by the laboratories. In the Netherlands, hospital pharmacies have resigned themselves to manufacturing the molecules they lack.
🛑 Story ExplainedSpoiler Warning
Our story explained section breaks down the complex narrative of Médicaments : Les Profits de la pénurie. The full story follows a progression that challenges typical tropes, leading to a climax that requires careful analysis.
🏆 Final Verdict
5 / 5 Stars
A triumphant piece of cinema that blends gripping narrative with breathtaking visuals.
Related Movies
Latest Reviews & Explanations
In-depth reviews, endings explained & more























